1-20 of 183
Anil K. Sood
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2-C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors

Thomas Welte, Veena K. Vuttaradhi, Eleonora Y. Khlebus, Allison Brodsky, Alejandra Flores Legarreta, Joseph Celestino, Reid T. Powell, Clifford C. Stephan, Nghi Nguyen, Jian Li, Shiro Takamatsu, Katherine Calzoncinth, Anil K. Sood, David M. Gershenson, P. Andrew Futreal, Barrett Lawson, Robert Tyler. Hillman
Journal: Cancer Research
Cancer Res (2024)
https://doi.org/10.1158/0008-5472.CAN-24-2341
Published: 09 December 2024
View article titled, Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2-C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors
Open the PDF for Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2-C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract 3847: Dual targeting of EGFL6 and VEGF-A to overcome immune suppression in ovarian cancer

Sujanitha Umamaheswaran, Lingegowda S. Mangala, Robiya Joseph, Nicholas B. Jennings, Mark S. Kim, Yunfei Wen, Emine Bayraktar, Ningyan Zhang, Zhiqiang An, Anil K. Sood
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3847.
https://doi.org/10.1158/1538-7445.AM2024-3847
Published: 22 March 2024
View article titled, Abstract 3847: Dual targeting of EGFL6 and VEGF-A to overcome immune suppression in ovarian cancer
Journal Articles

Abstract 7549: Overcoming resistance to anti-VEGF therapy via epigenetic regulation of BARD1

Emine Bayraktar, Cristian Rodriguez-Aguayo, Elaine Stur, Sudhir Kumar, Lingegowda S. Mangala, Nazende Nur Bayram, Pahul Hanjra, Sara Corvigno, Stephen Baylin, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7549.
https://doi.org/10.1158/1538-7445.AM2024-7549
Published: 22 March 2024
View article titled, Abstract 7549: Overcoming resistance to anti-VEGF therapy via epigenetic regulation of BARD1
Journal Articles

Abstract 3371: PRMT blockade induces defective DNA replication stress response via ATR suppression and synergizes with PARP inhibition

Deepa Bisht, Yang Li, Lacey E. Dobrolecki, Christina Sallas, Xudong Zhang, Travis D. Kerr, Yalong Wang, Sharad Awasthi, Babita Kaundal, Siqi Wu, Weiyi Peng, Marc L. Mendillo, Yiling Lu, Collene R. Jeter, Guang Peng, Jinsong Liu, Shannon N. Westin, Anil K. Sood, Michael T. Lewis, Jishnu Das, S. Stephen Yi, Mark T. Bedford, Daniel J. McGrail, Nidhi Sahni
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3371.
https://doi.org/10.1158/1538-7445.AM2024-3371
Published: 22 March 2024
View article titled, Abstract 3371: PRMT blockade induces defective DNA replication stress response via ATR suppression and synergizes with PARP inhibition
Journal Articles

Abstract 3344: Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA binding proteins

Babita Kaundal, Daniel J. McGrail, Yang Li, Roger S. Smith, Bin Feng, Hui Dai, Limei Hu, Briana Dennehey, Sharad Awasthi, Marc L. Mendillo, Anil K. Sood, Gordon B. Mills, Shiaw-Yih Lin, S. Stephen Yi, Nidhi Sahni
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3344.
https://doi.org/10.1158/1538-7445.AM2024-3344
Published: 22 March 2024
View article titled, Abstract 3344: Widespread <em>BRCA1/2</em>-independent homologous recombination defects are caused by alterations in RNA binding proteins
Journal Articles

Abstract 6407: Identification of novel chemotherapy-related CHIP variations in patients with high-grade serous ovarian cancer

Sara Corvigno, Amma Asare, Jun Yao, Li Zhao, Nicole Fleming, Joseph Celestino, Richard A. Hajek, Ency A. Arboleda Goette, Ridge T. Rogers, Tri V. Nguyen, Raymond N. Montoya, Karen H. Lu, Amir A. Jazaeri, Shannon N. Westin, Anil K. Sood, Sanghoon Lee
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6407.
https://doi.org/10.1158/1538-7445.AM2024-6407
Published: 22 March 2024
View article titled, Abstract 6407: Identification of novel chemotherapy-related CHIP variations in patients with high-grade serous ovarian cancer
Journal Articles

Abstract 5070: Landscape of clonal hematopoiesis prior to PARP inhibitor treatment in patients with ovarian cancer

Amma Asare, Sara Corvigno, Jun Yao, Li Zhao, Nicole D. Fleming, Joseph Celestino, Richard A. Hajek, Mark S. Kim, Alejandra Flores Legarreta, Karen H. Lu, Koichi Takahashi, P Andrew Futreal, Amir A. Jazaeri, Shannon N. Westin, Anil K. Sood, Sanghoon Lee
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5070.
https://doi.org/10.1158/1538-7445.AM2024-5070
Published: 22 March 2024
View article titled, Abstract 5070: Landscape of clonal hematopoiesis prior to PARP inhibitor treatment in patients with ovarian cancer
Journal Articles

Abstract 4742: Targeting the RNA-binding protein LARP1 overcomes therapeutic resistance in ovarian cancer

Abdelrahman M. Elsayed, Paola Amero, Emine Bayraktar, Anil K. Sood, Gabriel Lopez-Berestein, Cristian Rodriguez-Aguayo
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4742.
https://doi.org/10.1158/1538-7445.AM2024-4742
Published: 22 March 2024
View article titled, Abstract 4742: Targeting the RNA-binding protein LARP1 overcomes therapeutic resistance in ovarian cancer
Journal Articles

Abstract A077: The utility of surgical minimal residual disease after frontline treatment for prognostic and investigational opportunities in advanced ovarian cancer

Anne Knisely, Roni Nitecki, J. Alejandro Rauh-Hain, R. Tyler Hillman, Jolyn S. Taylor, Lois M. Ramondetta, Michaela O. Grinsfelder, Lauren P. Cobb, David M. Boruta, Gwyn Richardson, Pamela T. Soliman, Aaron Shafer, Shannon N. Westin, Nicole D. Fleming, Travis T. Sims, Anil K. Sood, Pedro T. Ramirez, Karen H. Lu, Amir A. Jazaeri
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): A077.
https://doi.org/10.1158/1538-7445.OVARIAN23-A077
Published: 04 March 2024
View article titled, Abstract A077: The utility of surgical minimal residual disease after frontline treatment for prognostic and investigational opportunities in advanced ovarian cancer
Journal Articles

Abstract A024: High throughput screen for identifying inducers of Autophagic Cell Death in Ovarian Carcinoma

Pahul Hanjra, Andrea Liu, Marc Ferrer, Anil K. Sood, Yunfei Wen
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): A024.
https://doi.org/10.1158/1538-7445.OVARIAN23-A024
Published: 04 March 2024
View article titled, Abstract A024: High throughput screen for identifying inducers of Autophagic Cell Death in Ovarian Carcinoma
Journal Articles

Abstract 5782: The dynamic immune behavior of primary and metastatic tumors of ovarian cancer

Elaine Stur, Fuduan Peng, Pang-ning Teng, Emine Bayraktar, Min Hu, Sara Corvigno, David J. Brown, Sanghoon Lee, Kathleen N. Moore, Nicholas W. Bateman, Kathleen M. Darcy, George L. Maxwell, Thomas Conrads, Nicole Fleming, Nicholas Navin, Linghua Wang, Anil K. Sood
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5782.
https://doi.org/10.1158/1538-7445.AM2023-5782
Published: 04 April 2023
View article titled, Abstract 5782: The dynamic immune behavior of primary and metastatic tumors of ovarian cancer
Journal Articles

Abstract 2720: Enhancing oral delivery of plant-derived vesicles

Yuan Liu, Adrian Lankenau-Ahumada, Emine Bayraktar, Paul Schwartz, Mamur Chowdhury, Sixiang Shi, Manu M. Sebastian, Htet Khant, Natalia De Val, Zuliang Jie, Nicholas B. Jennings, Cristian Rodriguez-Aguayo, Jody Swain, Elaine Stur, Lingegowda S. Mangala, Yutuan Wu, Supriya Nagaraju, Brooke Erimas, Chun Li, Gabriel Lopez-Berestein, Janet Braam, Anil K. Sood
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2720.
https://doi.org/10.1158/1538-7445.AM2023-2720
Published: 04 April 2023
View article titled, Abstract 2720: Enhancing oral delivery of plant-derived vesicles
Journal Articles

Abstract 528: Mechanisms and rational combinations with gp-2250, a novel oxathiazine derivative, in ovarian cancer

Mark S. Kim, Deanna Glassman, Adrian Lankenau Ahumada, Emine Bayraktar, Nicholas B. Jennings, Robiya Joseph, Sanghoon Lee, Robert L. Coleman, Anil K. Sood
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 528.
https://doi.org/10.1158/1538-7445.AM2023-528
Published: 04 April 2023
View article titled, Abstract 528: Mechanisms and rational combinations with gp-2250, a novel oxathiazine derivative, in ovarian cancer
Journal Articles

Abstract 1463: Fxr1 is an oncogenic driver in ovarian cancer

Jasmine George, Ishaque P. Kadamberi, Anjali Geethadevi, Sudhir Kumar, Sonam Mittal, Cristian Rodriguez-Aguayo, Lingegowda S. Mangala, Anil K. Sood, Sunila Pradeep, Pradeep Chaluvally-Raghavan
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1463.
https://doi.org/10.1158/1538-7445.AM2023-1463
Published: 04 April 2023
View article titled, Abstract 1463: Fxr1 is an oncogenic driver in ovarian cancer
Journal Articles

Abstract 6001: Epigenetic regulation of BARD1 confers resistance to anti-VEGF therapy in ovarian cancer

Emine Bayraktar, Cristian Rodriguez-Aguayo, Sudhir Kumar, Elaine Stur, Lingegowda S. Mangala, Stephen Baylin, Gabriel Lopez-Berestein, Sunila Pradeep, Anil K. Sood
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6001.
https://doi.org/10.1158/1538-7445.AM2023-6001
Published: 04 April 2023
View article titled, Abstract 6001: Epigenetic regulation of BARD1 confers resistance to anti-VEGF therapy in ovarian cancer
Journal Articles

Abstract 3249: Targeting polyploid giant cancer cells to overcome resistance to PARP inhibitors in ovarian cancer

Xudong Zhang, Jun Yao, Xiaoran Li, Na Niu, Yan Liu, Anil K. Sood, Jinsong Liu
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3249.
https://doi.org/10.1158/1538-7445.AM2022-3249
Published: 15 June 2022
View article titled, Abstract 3249: Targeting polyploid giant cancer cells to overcome resistance to PARP inhibitors in ovarian cancer
Journal Articles

Abstract 4135: Initial clinicopathologic and molecular characterization of minimal residual disease detected by second look laparoscopy after completion of frontline surgery and chemotherapy in patients with advanced stage ovarian cancer

Roni Nitecki, Minghao Dang, Sanghoon Lee, Bryan Fellman, J Alejandro Rauh-hain, Jolyn Taylor, Lois Ramondetta, Michaela Grinsfelder, Lauren Cobb, David M. Boruta, Pamela T. Soliman, Aaron Shafer, Nicole D. Fleming, Shannon N. Westin, Anil K. Sood, Chris Tanguma, Pedro T. Ramrez, Karen H. Lu, Linghua Wang, Amir A. Jazaeri
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 4135.
https://doi.org/10.1158/1538-7445.AM2022-4135
Published: 15 June 2022
View article titled, Abstract 4135: Initial clinicopathologic and molecular characterization of minimal residual disease detected by second look laparoscopy after completion of frontline surgery and chemotherapy in patients with advanced stage ovarian cancer
Journal Articles

Abstract 2484: Hyperpolarized magnetic resonance spectroscopy assessment of the metabolic effects of glutaminase inhibitor therapy in an ovarian cancer model

Deanna Glassman, Mark S. Kim, Prasanta Dutta, Charles V. Kingsley, Emine Bayraktar, Yutuan Wu, Elaine Stur, Lingegowda S. Mangala, Katherine Foster, Sanghoon Lee, Timothy A. Yap, Shannon N. Westin, Pratip Bhattacharya, Anil K. Sood
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2484.
https://doi.org/10.1158/1538-7445.AM2022-2484
Published: 15 June 2022
View article titled, Abstract 2484: Hyperpolarized magnetic resonance spectroscopy assessment of the metabolic effects of glutaminase inhibitor therapy in an ovarian cancer model
Journal Articles

Abstract 1550: Elucidating the role of ADAMTS9AS2 lncRNA in ovarian cancer

Emine Bayraktar, Guy Katz, Dahai Jiang, Cristian Rodriguez-Aguayo, Lingegowda S. Mangala, Santosh K. Dasari, Elaine Stur, Cristina Ivan, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1550.
https://doi.org/10.1158/1538-7445.AM2022-1550
Published: 15 June 2022
View article titled, Abstract 1550: Elucidating the role of ADAMTS9AS2 lncRNA in ovarian cancer
Journal Articles

Abstract 1175: Spatially resolved transcriptomics to understand mechanisms of response to neoadjuvant chemotherapy

Elaine Stur, Sara Corvigno, Mingchu Xu, Ken Chen, Sanghoon Lee, Jinsong Liu, Emilly Ricco, Nicole Fleming, Emine Bayraktar, Daniel Kraushaar, Jianhua Zhang, Anil K. Sood
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1175.
https://doi.org/10.1158/1538-7445.AM2022-1175
Published: 15 June 2022
View article titled, Abstract 1175: Spatially resolved transcriptomics to understand mechanisms of response to neoadjuvant chemotherapy